Biotech investors remain cautious in a stabilizing funding environment

[cafead]

via As biotechs pull resources out of thinner budgets, investors are still being cautious with their investments compared to funding highs seen a few years ago.

Experts deliberated the regulatory and financial factors influencing the current state of oncology clinical trials at the 13th Annual Clinical Trials in Oncology East Coast 2024 conference, being held 9 – 10 July in Burlington, Massachusetts.

article source